MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 5.56
-0.01 (-0.18%)
Jun 3, 2026, 2:00 PM CST
MARX Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 42.92 | -96.83 | -12.92 | 2.83 | 4.43 |
Depreciation & Amortization | 18.33 | 17.43 | 4.57 | 1.95 | - |
Other Amortization | 1.2 | 0.54 | 0.02 | - | - |
Loss (Gain) From Sale of Assets | -210.84 | - | - | 0.1 | - |
Loss (Gain) on Equity Investments | - | - | - | - | -4.97 |
Stock-Based Compensation | 0.55 | - | - | - | - |
Provision & Write-off of Bad Debts | 2.69 | 7.61 | 2.89 | 0.99 | - |
Other Operating Activities | 16.99 | -1.11 | -5.82 | -2.04 | -0.14 |
Change in Accounts Receivable | 47.31 | -26.77 | -40.84 | 5.04 | - |
Change in Inventory | -30.37 | -84.92 | -6.65 | -2.98 | - |
Change in Accounts Payable | -38.08 | 65.06 | 3.13 | -1.05 | 0.89 |
Change in Unearned Revenue | -7.99 | 10.34 | 14.82 | - | - |
Change in Other Net Operating Assets | 8.57 | 1.45 | 23.66 | 6.59 | 0.11 |
Operating Cash Flow | -148.73 | -107.18 | -17.13 | 11.44 | 0.31 |
Operating Cash Flow Growth | - | - | - | 3566.35% | - |
Capital Expenditures | -9.34 | -206 | -1.04 | -0.7 | - |
Sale of Property, Plant & Equipment | 0.06 | 0.24 | - | - | - |
Cash Acquisitions | -47.1 | -67.67 | -72.39 | 0.18 | - |
Divestitures | -23.73 | - | - | - | - |
Sale (Purchase) of Intangibles | -4.78 | -12.56 | -0.7 | - | - |
Investment in Securities | 1.5 | -3.5 | - | - | - |
Other Investing Activities | 1.79 | 3.01 | -0.97 | -0.28 | -0.05 |
Investing Cash Flow | -81.6 | -286.48 | -75.1 | -0.79 | -0.05 |
Short-Term Debt Issued | 28.22 | 98 | - | 10 | - |
Long-Term Debt Issued | 23.23 | 170.31 | - | - | - |
Total Debt Issued | 51.45 | 268.31 | - | 10 | - |
Short-Term Debt Repaid | - | - | -25.99 | - | - |
Long-Term Debt Repaid | -17.75 | -2.81 | -1.85 | -1.7 | - |
Total Debt Repaid | -17.75 | -2.81 | -27.85 | -1.7 | - |
Net Debt Issued (Repaid) | 33.7 | 265.5 | -27.85 | 8.3 | - |
Issuance of Common Stock | 64 | 50 | 251.76 | - | - |
Common Dividends Paid | - | - | -6.59 | -7.35 | - |
Other Financing Activities | 90.72 | - | - | - | - |
Financing Cash Flow | 188.42 | 315.5 | 217.33 | 0.95 | - |
Net Cash Flow | -41.9 | -78.16 | 125.1 | 11.6 | 0.27 |
Free Cash Flow | -158.06 | -313.18 | -18.17 | 10.74 | 0.31 |
Free Cash Flow Growth | - | - | - | 3343.27% | - |
Free Cash Flow Margin | -24.86% | -50.66% | -6.27% | 9.71% | - |
Free Cash Flow Per Share | -0.30 | -0.63 | -0.06 | 0.03 | 0.01 |
Cash Interest Paid | 13.35 | 2.21 | 0.37 | 0.11 | - |
Cash Income Tax Paid | -1.86 | 0.08 | 4.65 | 4.12 | - |
Levered Free Cash Flow | -311.71 | -292.53 | -58.58 | -38.72 | - |
Unlevered Free Cash Flow | -303.15 | -291.14 | -58.34 | -38.65 | - |
Change in Working Capital | -20.56 | -34.83 | -5.88 | 7.61 | 0.99 |